Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal Dysbiosis and Immune Reconstitution After Allo-HSCT
NCT03616015Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Quality of iNKT reconstitution after HSCT at Day 90. Status: unknown.
Beyond the preview
Go deeper on NCT03616015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616015.